FARRA, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 11.584
EU - Europa 7.719
AS - Asia 5.387
SA - Sud America 544
AF - Africa 174
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 25.470
Nazione #
US - Stati Uniti d'America 11.351
PL - Polonia 1.817
SG - Singapore 1.798
CN - Cina 1.462
IT - Italia 1.432
DE - Germania 911
SE - Svezia 866
HK - Hong Kong 465
VN - Vietnam 463
UA - Ucraina 456
FR - Francia 427
BR - Brasile 404
RU - Federazione Russa 396
GB - Regno Unito 387
KR - Corea 290
FI - Finlandia 263
TR - Turchia 240
NL - Olanda 217
BD - Bangladesh 196
IN - India 142
CA - Canada 132
IE - Irlanda 129
BG - Bulgaria 116
MA - Marocco 66
BE - Belgio 65
MX - Messico 60
JP - Giappone 54
AU - Australia 44
ES - Italia 40
AR - Argentina 37
CH - Svizzera 36
IQ - Iraq 30
SN - Senegal 28
PK - Pakistan 26
IR - Iran 25
SA - Arabia Saudita 23
ZA - Sudafrica 22
CZ - Repubblica Ceca 21
PH - Filippine 21
CO - Colombia 20
AT - Austria 18
EG - Egitto 18
VE - Venezuela 18
TH - Thailandia 17
CL - Cile 16
EC - Ecuador 15
ID - Indonesia 15
IL - Israele 14
UZ - Uzbekistan 14
GR - Grecia 13
LU - Lussemburgo 13
TW - Taiwan 13
JO - Giordania 11
KE - Kenya 11
PT - Portogallo 11
PY - Paraguay 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
EU - Europa 10
MY - Malesia 10
RS - Serbia 10
DZ - Algeria 9
LT - Lituania 9
PE - Perù 9
DK - Danimarca 8
HR - Croazia 8
AZ - Azerbaigian 7
HU - Ungheria 7
KZ - Kazakistan 7
SI - Slovenia 7
NO - Norvegia 6
UY - Uruguay 6
BO - Bolivia 5
CR - Costa Rica 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
EE - Estonia 4
GD - Grenada 4
HN - Honduras 4
KG - Kirghizistan 4
KH - Cambogia 4
MU - Mauritius 4
NP - Nepal 4
PA - Panama 4
AL - Albania 3
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
LB - Libano 3
MN - Mongolia 3
OM - Oman 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GG - Guernsey 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 25.434
Città #
Warsaw 1.708
Ashburn 1.251
Woodbridge 1.039
Singapore 1.037
Ann Arbor 923
Fairfield 915
Chandler 828
Houston 629
San Jose 545
Trieste 478
Hong Kong 437
Jacksonville 435
Wilmington 424
Beijing 353
Hefei 349
Seattle 346
Cambridge 298
Seoul 274
Princeton 211
Boardman 198
Los Angeles 194
Izmir 183
Dearborn 164
Chicago 150
Santa Clara 150
The Dalles 133
Ho Chi Minh City 127
Dublin 124
Columbus 119
Sofia 115
Hanoi 112
Lauterbourg 112
Council Bluffs 109
Moscow 104
Dallas 96
Zgierz 90
Helsinki 87
London 87
Milan 83
New York 78
Düsseldorf 76
Munich 76
Frankfurt am Main 70
Buffalo 67
Casablanca 55
San Diego 53
Brussels 52
Orem 49
São Paulo 43
Atlanta 38
Bremen 38
Montreal 37
Turku 37
Ottawa 34
North Bergen 33
Chennai 32
Redmond 32
Tokyo 32
Guangzhou 31
Kunming 31
Mestre 31
Phoenix 30
Denver 29
Shanghai 29
Dakar 28
Washington 28
Da Nang 27
Falls Church 27
Redwood City 27
Sydney 25
Toronto 25
Bern 24
Tianjin 24
Jinan 23
Nanjing 23
Rome 22
Haiphong 21
San Francisco 21
Venezia 21
Duino-Aurisina 20
Naples 20
Poplar 20
Brooklyn 19
Des Moines 19
Dong Ket 18
Kocaeli 18
Redondo Beach 18
Grafing 17
Napoli 17
Stockholm 17
Boston 16
Paris 16
Hebei 15
Johannesburg 15
Memphis 15
Padova 15
Amsterdam 14
Fagagna 14
Nanchang 14
Campinas 13
Totale 16.846
Nome #
Polysaccharides for the delivery of antitumor drugs 495
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 479
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 476
Potential applications of nanocellulose-containing materials in the biomedical field 466
Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules 457
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 450
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 425
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 397
Use of low field NMR for the characterization of gels and biological tissues 378
Physical characterization of alginate–Pluronic F127 gel for endoluminal NABDs delivery 358
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 358
Strategies for delivery of siRNAs to ovarian cancer cells 335
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 321
Therapeutic potential and delivery strategies for nucleic acid-based drugs 301
Characterization of PLLA scaffolds for biomedical applications 301
The role of the transcription factor E2F1 in hepatocellular carcinoma 297
Exploring the Shape Influence on Melting Temperature, Enthalpy, and Solubility of Organic Drug Nanocrystals by a Thermodynamic Model 296
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 287
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 286
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 284
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 281
Ottimizzazione di hydrogel alginato-pluronico per il rilascio di farmaci basati sul DNA 279
Thermo-responsive hydrogels from cellulose-based polyelectrolytes and catanionic vesicles for biomedical application 277
Guar gum/borax hydrogel: rheological, low field NMR and release characterizations 273
2D DYNAMICAL SIMULATION OF A VIBRATIONAL MILL 273
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 273
Mathematical modeling of drug release from natural polysaccharides based matrices 271
Use of Low field NMR for the characterisation of gels and biological tissues 270
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 267
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 262
Membranes in Drug Delivery 261
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 255
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 254
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 253
Modulating carbohydrate-based hydrogels as viscoelastic lubricant substitute for articular cartilages 251
Drug delivery from polymeric matrices 246
Designing of polymeric gels mimicking the normal and fibrotic liver tissues: Effect of viscoelasticity on cells adhesion and survival 246
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 241
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 238
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 236
Translation Elongation 236
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 235
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 233
Can rheology be useful in the cystic fibrosis frame 232
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 227
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 226
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 221
Swelling of viscoelastic matrices by viscoelastic fluids 219
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway 219
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 214
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 212
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 211
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 207
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 205
null 203
ANALYSIS AND MODELLING OF THE DISSOLUTION OF POLYDISPERSED SPHERICAL DRUG PARTICLES 202
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 200
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 199
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 196
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 195
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 195
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 195
Topological characterization of a bacterial cellulose - acrylic acid polymeric matrix 192
Synthesis and Spontaneous Polymerization of Oligo(ethyleneglycol)-Conjugated Benzofulvene Macromonomers.A Polymer Brush Forming a Physical Hydrogel 189
Drug delivery and mathematical modeling: an historical perspective 189
Hydrogels mesh size evaluation 188
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 187
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 187
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 187
null 184
Improving siRNA Bio-Distribution and Minimizing Side Effects 183
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 177
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 176
Potential applications of small interferring RNA in the cardiovascular field 173
E2F1 as a molecular drug target in ovarian cancer 171
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer 171
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 168
Charactherization of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 168
Nucleic Acids-based Aptamers and their applications 168
Rheological properties of aqueous Pluronic-alginate systems containing liposomes 167
Uso di small interfering RNA (SIRNA) per il trattamento di patologie caratterizzate da iperproliferazione cellulare 166
Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery 164
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 164
null 162
Reduction of melting temperature and enthalpy of drug crystals: theoretical aspects 162
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 160
An Overview of siRNA Delivery Strategies for Urological Cancers 160
“The expression levels of the translational factors eEF1A1/2 correlate with the cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade” 159
Drug Nanocrystals: theoretical background of solubility increase and dissolution rate enhancement 159
USO SINERGICO DELLA REOLOGIA E DELLA RISONANZA MAGNETICA NUCLEARE A BASSO CAMPO PER CARATTERIZZARE L’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA 155
Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system 154
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells 153
Characterisation of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 150
null 150
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 149
Study on Polymer-Surfactant Interactions for the Improvement of Drug Delivery Systems Wettability 149
SIMPLE, BIOCOMPATIBLE AND COST-EFFECTIVE INULIN BASED siRNA DELIVERY SYSTEMS 148
null 148
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 146
Drug delivery and in vivo absorption 145
Totale 23.664
Categoria #
all - tutte 68.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 0 0 163
2021/20221.562 40 87 58 207 38 140 111 62 137 129 183 370
2022/20232.489 232 379 247 362 222 358 39 197 258 46 108 41
2023/20241.421 78 84 89 81 166 165 194 262 26 86 106 84
2024/20252.993 34 93 180 252 313 254 192 156 416 448 326 329
2025/20266.966 830 343 436 630 606 621 926 185 800 908 340 341
Totale 25.923